Wikisage, the free encyclopedia of the second generation, is digital heritage
Riluzole: Difference between revisions
Jump to navigation
Jump to search
(Created page with "Rhone Poulenc medicament marketed as natrium channel blocking agent") |
(→ATC) |
||
| (9 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
Rhone Poulenc medicament marketed as natrium channel blocking agent | Riluzole Rhone Poulenc is a medicament marketed as natrium channel blocking agent with a modest benefit on [[Amyotrophic_lateral_sclerosis| ALS]]. | ||
<gallery>File:Riluzole.svg.png|6-(Trifluormethoxy)-1,3-benzothiazol-2-amine</gallery> | |||
{{Wikidata|Q415744}} | |||
==ATC== | |||
{| style="background:Ivory; color:black" border=1 cellspacing=1 cellpadding=5 | |||
|colspan=2| <center> | |||
: [[wikipedia:riluzole|riluzole]] | |||
<ref> | |||
[https://www.whocc.no/atc_ddd_index/?code=N07XX02 N07xx02]</ref></center> | |||
|} | |||
{{refs}} | |||
[[Category:anticonvulsants]] | |||
